| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2082004 | Drug Discovery Today: Disease Mechanisms | 2006 | 6 Pages |
Abstract
Chronic obstructive pulmonary disease (COPD) is mainly characterized by airflow limitation and abnormal inflammatory responses. These characteristics can be mimicked by excessive acetylcholine (ACh), the transmitter of parasympathetic axons, and anticholinergic treatment improves airflow in COPD patients. Recently, several non-neuronal sources of ACh have been identified and their release mechanisms differ from that of neurons. This non-neuronal ACh is an important candidate to contribute to COPD pathology, particularly in those regions of the lung that are spared by nerves.
Section editors:Maria Belvisi – Imperial College School of Medicine, London, UKStuart Farrow – GlaxoSmithKline, Stevenage, UK
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Wolfgang Kummer, Katrin S. Lips,